Camillo Therapeutics, Inc

Biodiscovery LLC is a leading provider of optical genome mapping solutions based in Ann Arbor, MI. Their innovative technology allows clinicians and researchers to accurately analyze genomic variations, from single nucleotide variants to structural variants, enabling comprehensive disease identification and treatment. With their state-of-the-art mapping systems and analysis software, Biodiscovery is empowering the healthcare community to make breakthroughs in oncology, genetic diseases, and cell bioprocessing, ultimately improving health outcomes for patients worldwide. Biodiscovery's optical genome mapping solutions have gained recognition globally, with over 500 publications citing their technology. By revealing hidden variations responsible for deleterious effects and identifying new druggable targets, Biodiscovery is driving advancements in cancer research and genetic disease understanding. Their commitment to customer-centered innovations and comprehensive interpretation of variant data is transforming the way the world sees the genome, moving health and hope forward for patients and their families.Generated from the website

Akadeum Life Sciences has developed a faster, easier way to separate cells from biological samples by using buoyant microbubbles.

Esperion Therapeutics, Inc. is a biopharmaceutical company based in Ann Arbor, MI, that focuses on advancing cardiovascular disease management through innovative treatments and partnerships. The company has two approved therapies in the US and Europe, leveraging a unique mechanism of action to enhance global access to its medications. With a commitment to scientific discovery, Esperion is at the forefront of investigating ACLY biology, having introduced the first ACLY inhibitor to the market. The organization utilizes cutting-edge discovery technology and data science to uncover new therapeutic opportunities and develop next-generation inhibitors targeting life-threatening diseases. Generated from the website